IVF
name pending profile ingest
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2026
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Mariner, LLC | 100.00K | New | $272,000 | 0.0% | New | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 16.85K | New | $45,825 | 0.0% | New | 1 | SEC ↗ ×2 |
| 3 | UBS Group AG | 3.32K | New | $9,033 | 0.0% | New | 1 | SEC ↗ |
| 4 | Citigroup Inc | 15 | New | $41 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Mariner, LLC | $272,000 | 0.0% |
| Geode Capital Management | $45,825 | 0.0% |
| UBS Group AG | $9,033 | 0.0% |
| Citigroup Inc | $41 | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 6 holders, 192.05K shares, $522,383 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.